https://nyulangone.org/news/adding-new-vaccine-type-leading-immunotherapy-dramatically-reduced-melanoma-recurrence
NYU Langone Health System announced that a new therapy that combines mRNA technology with immunotherapy reduces the recurrence of melanoma by 44%
This is a stage 2 trial
”Among 107 study subjects who were injected with both the experimental vaccine, called mRNA-4157/V940, and the immunotherapy pembrolizumab, the cancer returned in 24 subjects (22.4 percent) within 3 years of follow-up, compared with 20 out of 50 (40 percent) who received only pembrolizumab.”
Congrats to Dr. Weber and his team!
It’s great living in the future!
Previous
Previous
As it should be!
Next
Next